http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-113528566-B

Outgoing Links

Predicate Object
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2319-50
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2319-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02E50-10
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-815
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-62
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-65
classificationIPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12R1-84
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-62
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-67
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-65
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N1-19
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-81
filingDate 2021-06-03-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2022-12-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2022-12-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-113528566-B
titleOfInvention A yeast recombinant expression vector and its construction method and application
abstract The invention relates to a yeast recombinant expression vector and its construction method and application. The yeast recombinant expression vector contains an expression frame, and the expression frame sequentially includes a gene of a target protein to be expressed located in the same cistron, and a protease cleavage site. The coding sequence of the point and the antibiotic resistance gene; the protease cleavage site can be specifically recognized and cut by the protease in yeast. The invention also provides the construction method of the yeast recombinant expression vector and its application in screening the recombinant yeast highly expressing the target protein. By applying the technical scheme of the present invention, the recombinant yeast with high expression of the target protein can be screened quickly and with high throughput. Compared with the prior art, the rescreening time is significantly reduced, the false positive rate is reduced, and the screening efficiency is improved. .
priorityDate 2021-06-03-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID4922
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419594614
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID100862683
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID683
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP13250
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458396415
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID4932
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419562967
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415824599
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID422789056
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID4932
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ02149
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419522826
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID123865
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID128841
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID159333
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID20384770
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID4922

Total number of triples: 38.